Liver Cancer PDX Model


PDX stands for Patient-Derived Xenografts, where the tissue or cells from a patient (usually tumor tissues) are implanted into an animal. It is also known as Patient-Derived-Tumor-Xenografts (PDTX).

Patient-derived Xenografts (PDX) are advanced preclinical oncology model for drug development. It offers a far better alternative for preclinical drug evaluation as compared to the conventional cell line-derived xenograft model.


Advantages of PDX


  • By maintaining genotypic and phenotypic diversity of patient tumor tissues, PDX is capable of capturing a more faithful representation of the human tumor's characteristics.

  • PDX preserves tumor stroma and tumor microenvironments.

  • Compared with cancer cell lines, PDX offers a more faithful representation of the mechanisms of tumor genesis and development.

  • Compared with cancer cell lines, PDX offers a better reflection of cancer patients' drug sensitivity and tolerance levels during drug screening.


Applications of PDX

  • Screening and biomarker development of anti-cancer drugs

  • Co-clinical trials of anti-cancer drugs

  • Precision medicine

  • Study on tumor mechanisms


Having successfully established more than 60 types of liver cancer PDX models, Shanghai Model Organisms has identified their key characteristics through the analysis of genomics, histopathology, growth characteristics, drug responses to standard treatments, etc. Our research has demonstrated that PDX is capable of replicating the heterogeneity of patient tumors in various aspects, including their molecular, genetic and histological complexities. Our range of PDX models allows highly-efficient testing and analysis of drug efficacy in different clinical settings. PDX tumors collected from our PDX models can also be used in preclinical trials to facilitate drug development by mimicking Phase II patient tumor sizes.


Process of Establishing PDX

图片1.png


Our PDX service offerings include:

  • PDX implantation to independently-developed immunodeficient NMG mice

  • F0 PDX generation and passaging with mature subcutaneous and organ inoculation techniques

  • Verification of PDX through pathological and molecular biological techniques

  • Long-term cryopreservation of PDX through cell culture technology


Our liver cancer PDX resources

图片2.png


Diagram of drug screening results using liver cancer PDX

图片3.png

Fig 1. Tumor growth curves of liver cancer PDX models after treatment with different drug groups by Shanghai Model Organisms



Popular articles

Workshop:Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

Learn more
Shanghai Model Organisms Jinshan R&D Base officially put into operation

After the base is put into operation, SMOC’s capability to provide genetically modified rat/mouse models and technical services including gene function research and drug development will be greatly enhanced.

Learn more